Stem cell therapy (University of Toronto)

N/A

Report date: 2023/01/12 15:47:34

Base Information

Drug NameStem cell therapy (University of Toronto)
Drug Alias NameBM-MSCs (allogeneic)Human allogeneic bone marrow-derived mesenchymal stem cells
ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Bone Marrow-derived
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsFrailtyOsteoporosisMusculoskeletal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBahamas
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Toronto - St. George Campus
China Registration ClassN/A

Develop Information

Active CompaniesCellcolabs Clinical LtdUniversity Of Toronto - St. George Campus
Inactive CompaniesN/A
Active IndicationsFrailtyOsteoporosisMusculoskeletal Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A